Developer docs
API playgroundTry for free, no card

Search company profiles

imaware

Full company profile

uuid0002em1

Namestring
imaware
Legal namestring
imaware
Websiteurl
imaware.health
Company typeenum
Private
Founded yearint
2019
Descriptiontext

imaware is a digital health company operating a white-label at-home diagnostic testing platform that enables consumers, employers, health systems, payors, pharmaceutical companies, and health/wellness brands to access biomarker testing through a configurable, API-first architecture. The platform offers more than 200 analytes spanning cardiovascular, metabolic, hormonal, liver/kidney, inflammation, STI, micronutrient, and food sensitivity panels, processed through CLIA-certified and CAP-accredited labs and accessible via at-home sample collection or through a network of 4,500+ Quest Diagnostics and LabCorp centers across all 50 U.S. states. All results are reviewed by licensed physicians and delivered through HIPAA- and SOC2-compliant patient portals, with integration points to telemedicine providers, EMRs, pharmacies, wearables, and third-party logistics partners.

The company operates a dual business model: a direct-to-consumer e-commerce channel selling branded at-home test kits priced $52-$169 each, and an enterprise B2B white-label platform licensed to partners under a subscription structure (one-time setup fee, monthly platform fee, variable per-end-user fees, plus integration services). The consumer product line includes dedicated panels for heart health, men's health, women's health, prostate cancer screening, prediabetes/diabetes screening, and testosterone monitoring. The B2B platform is the higher-margin, higher-stickiness segment, with white-label customization, branded test kits, and dedicated customer success management supporting partnership depth.

In October 2024, imaware acquired binx health's consumer testing business to expand into STI screening. In December 2024, SuperTruth acquired imaware to centralize healthcare data and improve AI model accuracy; imaware continues to operate as a brand and platform subsidiary, with the Data Trust Index framework subsequently deployed on its platform. The company is headquartered in Austin, Texas, with a headcount of 11-50 employees.

Short descriptiontext

imaware is an Austin-based digital health company operating a white-label at-home diagnostic testing platform offering 200+ biomarkers through CLIA-certified labs, serving both individual consumers via e-commerce and B2B partners (employers, health systems, payors, pharma, and wellness brands) via subscription-based white-label licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
at-home diagnostic testing, biomarker testing platform, white-label health testing, corporate wellness programs, clinical trial diagnostics
Industry4 codes
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
At-Home Diagnostic Testing Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Direct-to-Consumer Test Sales
TypeOne Time License
Description

One-time purchase of individual at-home test kits sold directly to consumers through e-commerce platform, ranging from $52-$169 per test depending on panel complexity.

imaware.health
2B2B White-Label Platform Licensing
TypeSubscription Recurring
Description

Enterprise partners license the imaware platform with one-time setup and implementation fee, plus monthly fixed platform fees and variable per-end-user fees. Includes biomarker test kit fees and clinician support.

imaware.health
3Integration Services
TypeProfessional Services
Description

Additional revenue from API integrations with labs, pharmacies, telemedicine providers, EMRs, wearables, and logistics providers performed by imaware's engineering team.

imaware.health
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details5 tiers
1Prostate Cancer Screening Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$89 regular price, $67 sale price. Measures PSA biomarker. Includes physician review and telehealth support.

imaware.health
2Men's Health & Wellness Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$169 regular price, $127 sale price (25% off with HOLIDAYHEALTH code). Comprehensive panel measuring cholesterol, inflammation, iron, vitamin D, testosterone, PSA, HbA1c. 11 biomarkers total.

imaware.health
3Prediabetes / Diabetes Screening Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$79 regular price, $60 sale price. Measures HbA1c, glucose, and estimated average glucose (EAG).

imaware.health
4Testosterone Monitoring Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$69 regular price, $52 sale price. Measures total testosterone levels for men.

imaware.health
5B2B White-Label Platform
ModelSubscriptionBilling cadenceMonthly
Notes

One-time setup fee plus monthly fixed platform fee plus variable per-end-user fees. Includes biomarker test kit fees and clinician support. Integration add-ons available.

imaware.health
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

imaware operates a white-label digital health platform for at-home biomarker testing, offering 200+ analytes processed through CLIA-certified and CAP-accredited labs. The platform is sold B2B to employers, health systems, payors, pharmaceutical companies, and wellness brands who deploy branded test kits and patient portals under their own identity. Direct-to-consumer branded test kits for prostate cancer, testosterone, men's/women's health, diabetes, and heart health are sold individually through imaware.health at $52–$169 per kit.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 95%+ of beta test members saw biomarker improvements after 6 months
+2 more records
Product overview1 text field

imaware is a health technology company offering a white-label diagnostic platform for at-home biomarker testing. The platform provides customizable panels from 200+ analytes through CLIA-certified, CAP-accredited labs, serving B2B partners including employers, health & wellness companies, clinical care providers, pharmaceutical companies, health payors, and health systems. Consumer products include branded at-home tests for heart health, men's health, women's health, prostate cancer screening, diabetes/prediabetes, and testosterone monitoring. The platform integrates with Quest/LabCorp lab networks, supports API connectivity for enterprise partners, and offers HIPAA-compliant patient portals with telehealth integration.

Product and service9 records
1Baseline Heart Health Test
CategoryConsumer at-home test kit
Description

At-home heart health test measuring cholesterol, glucose, and inflammation levels, priced at $89 and shipped to consumers for self-collection. Designed for individuals seeking preventive cardiovascular screening.

2Men's Health & Wellness Test
CategoryConsumer at-home test kit
Description

Comprehensive at-home men's health panel measuring hs-CRP, PSA, total cholesterol, ferritin, vitamin D, triglycerides, LDL-C, HDL-C, total testosterone, and HbA1c (11 biomarkers), priced at $169. Recommended as 'Best for men's health' by Healthline.

3Prostate Cancer Screening Test
CategoryConsumer at-home test kit
Description

At-home Prostate-Specific Antigen (PSA) prostate cancer screening test priced at $89, including physician review and telehealth support. Recommended as 'Best report' by Healthline.

4Testosterone Monitoring Test
CategoryConsumer at-home test kit
Description

At-home testosterone monitoring test measuring total testosterone levels, priced at $69. Recommended as 'Best for men's health' by Healthline.

5Prediabetes / Diabetes Screening Test
CategoryConsumer at-home test kit
Description

At-home diabetes screening test measuring estimated average glucose (EAG), fasting glucose, and HbA1c levels, priced at $79. Recommended as 'Best for physician-reviewed testing' by Healthline.

6Women's Health & Wellness Test
CategoryConsumer at-home test kit
Description

Comprehensive at-home women's health panel covering female hormones, lipids, micronutrients, and related biomarkers, priced at $169. Designed for women seeking preventive and wellness biomarker screening.

7imaware Diagnostic Platform
CategoryB2B white-label platform
Description

White-label B2B diagnostic platform enabling health systems, employers, payors, pharmaceutical companies, and wellness brands to offer at-home biomarker testing. Features customizable panels from 200+ analytes, HIPAA-compliant patient portals, results dashboards, telehealth integration, and API connectivity. Includes dedicated Customer Success Manager and clinician support.

8White-Label Testing Program
CategoryB2B white-label platform
Description

Private-label health testing solution allowing enterprise partners to rebrand test kits and the digital platform with their own branding. Includes access to 200+ biomarkers, lab integration with Quest and LabCorp, and ongoing support services with monthly fixed platform fees plus variable per-end-user fees.

9Biomarker Testing Panels
CategoryCustomizable biomarker panels
Description

Customizable biomarker test panels spanning cardiovascular (cholesterol, triglycerides, inflammation), metabolic (glucose, HbA1c, insulin), hormonal (testosterone, thyroid, cortisol), liver/kidney function, STI screening, 108 IgG food sensitivity, and micronutrient categories. Designed to be configured per partner or population.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-27
Description

SuperTruth acquired imaware in December 2024 and is now deploying its Data Trust Index framework on imaware's platform. The partnership reduced analysis time by 95% and eliminated 200+ hours of monthly manual processing on 105,000 oncology diagnostic records. SuperTruth filed a provisional patent for the Behavioral Integrity Index with imaware integration.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

imaware acquired binx health's consumer testing business, expanding into home-health testing category and becoming a leader in STI health screening. Transaction scales solutions for B2C patients and B2B partners.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership providing access to 4500+ Quest laboratory centers for sample collection, complementing at-home testing with in-person phlebotomy options.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership providing access to LabCorp laboratory network for sample processing, ensuring CLIA-certified and CAP-accredited testing capabilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as trusted health organization partner utilizing imaware's diagnostics platform for health solutions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as trusted health organization partner recognizing imaware's diagnostic platform capabilities.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Function Health sells comprehensive at-home biomarker panels directly to consumers and has positioned itself as a premium preventive health testing brand. It directly competes with imaware's premium men's and women's wellness panels.

TypeDirect peer
Description

LetsGetChecked offers at-home diagnostic test kits with both DTC and B2B/employer channels and CLIA-certified lab processing. It is a direct competitor on platform model, biomarker breadth, and enterprise sales motion.

TypeEmerging player
Description

Hims & Hers combines DTC telehealth with growing at-home lab testing capabilities, particularly in men's and women's health. It competes for the same consumer testing-and-treatment use cases as imaware's panels.

4Ro
TypeEmerging player
Description

Ro operates a vertically integrated telehealth and men's health platform that increasingly bundles at-home lab testing with virtual care. It overlaps with imaware's men's health and hormone testing offerings and B2B employer wellness channel.

TypeDirect peer
Description

Everlywell is a leading direct-to-consumer at-home testing company offering a broad menu of biomarker and wellness tests online. It is the most direct head-to-head competitor to imaware in the consumer at-home diagnostic testing category.

TypeRegional player
Description

23andMe is a direct-to-consumer genetic and health testing company. While focused on genomics rather than blood biomarkers, it competes for the same consumer health-Testing wallet and DTC channel.

TypeEmerging player
Description

Thorne offers direct-to-consumer supplements and biomarker testing with a focus on personalized health optimization. It overlaps with imaware on wellness-focused biomarker panels and shares a similar premium-DTC positioning.

8Cue Health
TypeEmerging player
Description

Cue Health builds connected at-home molecular diagnostic readers and tests (initially COVID, expanding to respiratory and sexual health). It is comparable as an at-home diagnostic hardware/reader competitor, though its device-based approach differs from imaware's kit-and-lab model.

TypeBroad incumbent
Description

Quest Diagnostics is a national clinical laboratory network and one of imaware's core lab processing partners. It is comparable both as a wholesale channel and as a broad incumbent that competes in consumer-initiated testing (e.g., Quest's own direct testing portal).

TypeOthers
Description

Labcorp is a major clinical laboratory network and imaware's other core lab partner. It also operates its own direct-to-consumer testing channel, making it both a critical supplier and a broad incumbent competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

imaware

At-Home Diagnostic Testing Platformimaware.health

imaware is an Austin-based digital health company operating a white-label at-home diagnostic testing platform offering 200+ biomarkers through CLIA-certified labs, serving both individual consumers via e-commerce and B2B partners (employers, health systems, payors, pharma, and wellness brands) via subscription-based white-label licensing.

What imaware does

imaware is a digital health company operating a white-label at-home diagnostic testing platform that enables consumers, employers, health systems, payors, pharmaceutical companies, and health/wellness brands to access biomarker testing through a configurable, API-first architecture. The platform offers more than 200 analytes spanning cardiovascular, metabolic, hormonal, liver/kidney, inflammation, STI, micronutrient, and food sensitivity panels, processed through CLIA-certified and CAP-accredited labs and accessible via at-home sample collection or through a network of 4,500+ Quest Diagnostics and LabCorp centers across all 50 U.S. states. All results are reviewed by licensed physicians and delivered through HIPAA- and SOC2-compliant patient portals, with integration points to telemedicine providers, EMRs, pharmacies, wearables, and third-party logistics partners.

The company operates a dual business model: a direct-to-consumer e-commerce channel selling branded at-home test kits priced $52-$169 each, and an enterprise B2B white-label platform licensed to partners under a subscription structure (one-time setup fee, monthly platform fee, variable per-end-user fees, plus integration services). The consumer product line includes dedicated panels for heart health, men's health, women's health, prostate cancer screening, prediabetes/diabetes screening, and testosterone monitoring. The B2B platform is the higher-margin, higher-stickiness segment, with white-label customization, branded test kits, and dedicated customer success management supporting partnership depth.

In October 2024, imaware acquired binx health's consumer testing business to expand into STI screening. In December 2024, SuperTruth acquired imaware to centralize healthcare data and improve AI model accuracy; imaware continues to operate as a brand and platform subsidiary, with the Data Trust Index framework subsequently deployed on its platform. The company is headquartered in Austin, Texas, with a headcount of 11-50 employees.

imaware firmographics

Firmographics
Name
imaware
Legal name
imaware
Website
https://imaware.health
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
imaware is an Austin-based digital health company operating a white-label at-home diagnostic testing platform offering 200+ biomarkers through CLIA-certified labs, serving both individual consumers via e-commerce and B2B partners (employers, health systems, payors, pharma, and wellness brands) via subscription-based white-label licensing.
Ownership category
akta.pro rank

imaware industry classification

Industry
Product category
At-Home Diagnostic Testing Platform
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • At-home diagnostic testing
  • Biomarker testing platform
  • White-label health testing
  • Corporate wellness programs
  • Clinical trial diagnostics

Where imaware is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

imaware business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Direct-to-Consumer Test Sales: One-time purchase of individual at-home test kits sold directly to consumers through e-commerce platform, ranging from $52-$169 per test depending on panel complexity.
  2. B2B White-Label Platform Licensing: Enterprise partners license the imaware platform with one-time setup and implementation fee, plus monthly fixed platform fees and variable per-end-user fees. Includes biomarker test kit fees and clinician support.
  3. Integration Services: Additional revenue from API integrations with labs, pharmacies, telemedicine providers, EMRs, wearables, and logistics providers performed by imaware's engineering team.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProstate Cancer Screening Test
Unit PricingPay-as-you-goMen's Health & Wellness Test
Unit PricingPay-as-you-goPrediabetes / Diabetes Screening Test
Unit PricingPay-as-you-goTestosterone Monitoring Test
SubscriptionMonthlyB2B White-Label Platform

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

imaware product offering

Product offering

Core offering

imaware operates a white-label digital health platform for at-home biomarker testing, offering 200+ analytes processed through CLIA-certified and CAP-accredited labs. The platform is sold B2B to employers, health systems, payors, pharmaceutical companies, and wellness brands who deploy branded test kits and patient portals under their own identity. Direct-to-consumer branded test kits for prostate cancer, testosterone, men's/women's health, diabetes, and heart health are sold individually through imaware.health at $52–$169 per kit.

Product overview

imaware is a health technology company offering a white-label diagnostic platform for at-home biomarker testing. The platform provides customizable panels from 200+ analytes through CLIA-certified, CAP-accredited labs, serving B2B partners including employers, health & wellness companies, clinical care providers, pharmaceutical companies, health payors, and health systems. Consumer products include branded at-home tests for heart health, men's health, women's health, prostate cancer screening, diabetes/prediabetes, and testosterone monitoring. The platform integrates with Quest/LabCorp lab networks, supports API connectivity for enterprise partners, and offers HIPAA-compliant patient portals with telehealth integration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Baseline Heart Health Test At-home heart health test measuring cholesterol, glucose, and inflammation levels, priced at $89 and shipped to consumers for self-collection. Designed for individuals seeking preventive cardiovascular screening.
  • Men's Health & Wellness Test Comprehensive at-home men's health panel measuring hs-CRP, PSA, total cholesterol, ferritin, vitamin D, triglycerides, LDL-C, HDL-C, total testosterone, and HbA1c (11 biomarkers), priced at $169. Recommended as 'Best for men's health' by Healthline.
  • Prostate Cancer Screening Test At-home Prostate-Specific Antigen (PSA) prostate cancer screening test priced at $89, including physician review and telehealth support. Recommended as 'Best report' by Healthline.
  • Testosterone Monitoring Test At-home testosterone monitoring test measuring total testosterone levels, priced at $69. Recommended as 'Best for men's health' by Healthline.
  • Prediabetes / Diabetes Screening Test At-home diabetes screening test measuring estimated average glucose (EAG), fasting glucose, and HbA1c levels, priced at $79. Recommended as 'Best for physician-reviewed testing' by Healthline.
  • Women's Health & Wellness Test Comprehensive at-home women's health panel covering female hormones, lipids, micronutrients, and related biomarkers, priced at $169. Designed for women seeking preventive and wellness biomarker screening.
  • imaware Diagnostic Platform White-label B2B diagnostic platform enabling health systems, employers, payors, pharmaceutical companies, and wellness brands to offer at-home biomarker testing. Features customizable panels from 200+ analytes, HIPAA-compliant patient portals, results dashboards, telehealth integration, and API connectivity. Includes dedicated Customer Success Manager and clinician support.
  • White-Label Testing Program Private-label health testing solution allowing enterprise partners to rebrand test kits and the digital platform with their own branding. Includes access to 200+ biomarkers, lab integration with Quest and LabCorp, and ongoing support services with monthly fixed platform fees plus variable per-end-user fees.
  • Biomarker Testing Panels Customizable biomarker test panels spanning cardiovascular (cholesterol, triglycerides, inflammation), metabolic (glucose, HbA1c, insulin), hormonal (testosterone, thyroid, cortisol), liver/kidney function, STI screening, 108 IgG food sensitivity, and micronutrient categories. Designed to be configured per partner or population.

Quantifiable outcome

  • 95%+ of beta test members saw biomarker improvements after 6 months
  • +2 more outcomes

Companies that use imaware

Customer profile

Named customers3 records

Segments7 records

Ideal customer profiles6 records

imaware technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability5 records

Feature6 records

imaware partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major and minor.

  • SuperTruthcoreStrategic or Co-development Partner · 27 April 2026SuperTruth acquired imaware in December 2024 and is now deploying its Data Trust Index framework on imaware's platform. The partnership reduced analysis time by 95% and eliminated 200+ hours of monthly manual processing on 105,000 oncology diagnostic records. SuperTruth filed a provisional patent for the Behavioral Integrity Index with imaware integration.
  • binx healthmajorStrategic or Co-development Partnerimaware acquired binx health's consumer testing business, expanding into home-health testing category and becoming a leader in STI health screening. Transaction scales solutions for B2C patients and B2B partners.
  • Quest DiagnosticscoreTechnology or IntegrationIntegration partnership providing access to 4500+ Quest laboratory centers for sample collection, complementing at-home testing with in-person phlebotomy options.
  • LabCorpcoreTechnology or IntegrationIntegration partnership providing access to LabCorp laboratory network for sample processing, ensuring CLIA-certified and CAP-accredited testing capabilities.
  • RecurominorStrategic or Co-development PartnerListed as trusted health organization partner utilizing imaware's diagnostics platform for health solutions.
  • Mayo ClinicminorStrategic or Co-development PartnerListed as trusted health organization partner recognizing imaware's diagnostic platform capabilities.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

imaware competitors and assessment

Company assessment

Direct peers

  • Function Health: Function Health sells comprehensive at-home biomarker panels directly to consumers and has positioned itself as a premium preventive health testing brand. It directly competes with imaware's premium men's and women's wellness panels.
  • LetsGetChecked: LetsGetChecked offers at-home diagnostic test kits with both DTC and B2B/employer channels and CLIA-certified lab processing. It is a direct competitor on platform model, biomarker breadth, and enterprise sales motion.
  • Everlywell: Everlywell is a leading direct-to-consumer at-home testing company offering a broad menu of biomarker and wellness tests online. It is the most direct head-to-head competitor to imaware in the consumer at-home diagnostic testing category.

Emerging players

  • Hims & Hers Health: Hims & Hers combines DTC telehealth with growing at-home lab testing capabilities, particularly in men's and women's health. It competes for the same consumer testing-and-treatment use cases as imaware's panels.
  • Ro: Ro operates a vertically integrated telehealth and men's health platform that increasingly bundles at-home lab testing with virtual care. It overlaps with imaware's men's health and hormone testing offerings and B2B employer wellness channel.
  • Thorne HealthTech: Thorne offers direct-to-consumer supplements and biomarker testing with a focus on personalized health optimization. It overlaps with imaware on wellness-focused biomarker panels and shares a similar premium-DTC positioning.
  • Cue Health: Cue Health builds connected at-home molecular diagnostic readers and tests (initially COVID, expanding to respiratory and sexual health). It is comparable as an at-home diagnostic hardware/reader competitor, though its device-based approach differs from imaware's kit-and-lab model.

Regional players

  • 23andMe: 23andMe is a direct-to-consumer genetic and health testing company. While focused on genomics rather than blood biomarkers, it competes for the same consumer health-Testing wallet and DTC channel.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is a national clinical laboratory network and one of imaware's core lab processing partners. It is comparable both as a wholesale channel and as a broad incumbent that competes in consumer-initiated testing (e.g., Quest's own direct testing portal).

Others

  • Labcorp: Labcorp is a major clinical laboratory network and imaware's other core lab partner. It also operates its own direct-to-consumer testing channel, making it both a critical supplier and a broad incumbent competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

imaware social profiles

Digital presence

imaware compliance and trust

Trust signal

Compliance4 records

imaware financial estimates

Financial estimate

Revenue estimate

Valuation estimate

imaware leadership team

Management profile

Number of profiles

Profiles3 records

imaware funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

imaware M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about imaware

What does imaware do?

imaware operates a white-label digital health platform for at-home biomarker testing, offering 200+ analytes processed through CLIA-certified and CAP-accredited labs. The platform is sold B2B to employers, health systems, payors, pharmaceutical companies, and wellness brands who deploy branded test kits and patient portals under their own identity. Direct-to-consumer branded test kits for prostate cancer, testosterone, men's/women's health, diabetes, and heart health are sold individually through imaware.health at $52–$169 per kit.

Is imaware a public or private company?

imaware is a private company. It is classified as corporate owned and is currently operating.

When was imaware founded?

imaware was founded in 2019. It employs 11 to 50 people.

Where is imaware based?

imaware is headquartered in Austin, United States, in the North America region.

How does imaware make money?

Three revenue lines are on record. Direct-to-Consumer Test Sales are the primary driver. The others are B2B White-Label Platform Licensing and integration Services.

Who are imaware's main competitors?

Direct peers on record are Function Health, LetsGetChecked and Everlywell. Emerging players are Hims & Hers Health, Ro, Thorne HealthTech and Cue Health. 23andMe is listed as a regional player. Quest Diagnostics is listed as a broad incumbent. Labcorp is listed as an others.

Does imaware have an API?

Yes. imaware offers a flexible API that covers all aspects of the lab journey, from ordering testing kits to lab results and all statuses in between. The API is designed so partners can own the entire end-to-end patient-facing experience. Partners can manage the entire experience or only portions, as the API works in concert with the hosted solution. Integrations can be added as an added service by imaware's engineering team, or partners can use the flexible API to perform integrations on their own.

What industry is imaware in?

imaware's product category is At-Home Diagnostic Testing Platform. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 621511 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HIT ConsultantLocke Bio Partners with imaware to Bring Comprehensive Lab Testing to TelehealthLocke Bio partnered with imaware to integrate comprehensive lab testing into its telehealth platform, enabling remote diagnostic services. The integration allows patients to complete testing in under five minutes without clinic visits, with services available to enterprise clients starting April 1, 2025.PR NewswireLocke Bio Partners with imaware to Bring Comprehensive Lab Testing to TelehealthLocke Bio, a telehealth platform, has partnered with imaware, a lab-testing provider, to integrate comprehensive diagnostic testing into its digital healthcare ecosystem across all 50 U.S. states. The collaboration eliminates the need for in-person lab visits, allowing telehealth providers to offer lab-validated treatments remotely through imaware's network of CLIA/CAP-certified labs. The integrated lab testing services will be available to Locke Bio's enterprise clients starting April 1, 2025.TmcnetSuperTruth Acquires imaware and Enables Future Of Reliable AI Data Management and Better Health OutcomesSuperTruth acquired imaware, a leader in at-home testing, to integrate its data infrastructure with imaware's diagnostic platform. The acquisition aims to centralize fragmented health data, with McKinsey data showing data-related inefficiencies cost U.S. healthcare over $265 billion annually. The companies expect the demand for integrated health solutions to reach $73.8 billion by 2030.PR NewswireSuperTruth Acquires imaware and Enables Future Of Reliable AI Data Management and Better Health OutcomesSuperTruth acquired imaware, a leader in at-home testing, to integrate its data infrastructure with imaware's diagnostic platform. The acquisition aims to centralize fragmented health data, with McKinsey data showing data-related inefficiencies cost U.S. healthcare over $265 billion annually. The companies expect integrated health solutions demand to reach $73.8 billion by 2030.VenturecapitalSuperTruth Acquires imaware to Revolutionize Healthcare Data ManagementSuperTruth has acquired imaware, a provider of at-home testing and health insight infrastructure, in a move designed to centralize first-party data. This acquisition aims to improve AI model accuracy and enable proactive health management through better data classification.ImawareHow Custom Health Test Kits Improve Patient Satisfaction and LoyaltyThe article discusses the growing popularity and benefits of custom at-home health test kits, which enhance patient satisfaction and loyalty by providing convenient, personalized health insights. It highlights how these tests address barriers to care such as accessibility and privacy while enabling proactive disease screening and better patient-provider communication. The piece also mentions imaware as a company providing custom biomarker panels and testing solutions to healthcare partners.ImawareFuel Your Business Growth: Top 10 Health & Wellness StrategiesThe article provides strategic guidance for businesses to navigate the rapidly growing global health and wellness market, which was valued at over $1.5 trillion in 2021. It outlines ten key strategies for growth, including identifying target markets, leveraging technology, and forming partnerships with entities like imaware. The piece emphasizes that companies must continuously innovate and utilize data-driven insights to remain competitive.VatorNewsimaware buys STI consumer testing business from binx healthImaware acquired binx health's consumer testing business, doubling its B2B clients and growing its patient count by 50% to over 15 million. Binx will focus on its point-of-care testing device, binx io, with distribution in 2024. The deal's financial terms were not disclosed.GlobeNewswireimaware acquires binx health’s consumer testing business, becoming a leader in STI health screeningimaware acquired binx health's at-home consumer testing business, expanding its home-testing footprint. binx health will retain its point-of-care molecular diagnostics division, which is excluded from the deal. The acquisition aims to strengthen imaware's position in the growing home-health testing market.GlobeNewswireimaware acquires binx health’s consumer testing business, becoming a leader in STI health screeningimaware acquired binx health's at-home consumer testing business, expanding its home-testing footprint. binx health will retain its point-of-care molecular diagnostics division, which is excluded from the deal. The acquisition aims to make imaware the leading STI at-home testing company with contracts from universities, clinics, and state health departments.